Ovarian Cancer
AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance
The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib.
Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test
Aspira said it will bring its experience in patient sample recruitment and ovarian cancer assay development to the collaboration.
InterVenn Biosciences Raises $34M in Series B Round to Commercialize Ovarian Cancer Test
The company also announced John Leite, the former leader of clinical business development activities at Illumina, had joined the firm as chief business officer.
Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China
A deal with Burning Rock will allow the test to be used in trials and clinics in China, and Myriad will license its technology to French and German pathology labs.
FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies
FoundationOne Liquid CDx can now be used as a companion diagnostic for therapies to treat advanced ovarian, breast, and non-small cell lung cancer.